KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q4 2025 value amounting to 0.64.

  • Alnylam Pharmaceuticals' Asset Utilization Ratio rose 2050.65% to 0.64 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.64, marking a year-over-year increase of 2050.65%. This contributed to the annual value of 0.81 for FY2025, which is 4480.1% up from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.64 for Q4 2025, which was up 2050.65% from 0.56 recorded in Q3 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Asset Utilization Ratio peaked at 0.64 during Q4 2025, and registered a low of 0.17 during Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.39, with a median of 0.39 in 2023.
  • As far as peak fluctuations go, Alnylam Pharmaceuticals' Asset Utilization Ratio skyrocketed by 7884.21% in 2021, and later crashed by 2777.12% in 2025.
  • Alnylam Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.24 in 2021, then increased by 23.47% to 0.29 in 2022, then skyrocketed by 62.74% to 0.48 in 2023, then grew by 11.67% to 0.53 in 2024, then rose by 20.51% to 0.64 in 2025.
  • Its Asset Utilization Ratio was 0.64 in Q4 2025, compared to 0.56 in Q3 2025 and 0.43 in Q2 2025.